CNMD logo

CONMED CORP

CNMDNYSE
πŸ† #1832 by market capEarnings Nov 3 Β· PostUS Equity
$615.55β–² $29.85 (+4.85%)
Simulated price
1hβ€”
24hβ–² 4.8%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$1.48B
Small Cap
πŸ“ˆRevenue Growth (YoY)
+5.2%
Slowing
πŸ“ŠGross Margin
54.8%
Healthy
πŸ’΅FCF Margin
9.8%
Moderate
βš–οΈP/S Ratio
1.1x
Cheap
Otter Score
62
Fair
No chart data available for CNMD.

Trading Snapshot

Day Range
$607.35 – $620.88
52-Week Range
$31.44 – $56.64
Volume
$4.26B
Avg Volume
$5.04B
Shares Outstanding
30.0M
Next Earnings
Oct 22, 2026

Fundamentals Snapshot

Annual Revenue
$1.37B
Last Q Revenue
$343M
P/E Ratio
26.8
P/S Ratio
1.1x
EPS (TTM)
$1.88
Dividend Yield
0.40%

Why Investors Own CNMD

  • βœ“High-growth profile β€” revenue up +53.9% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 52% gross margin and 20% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$1.37Bβ–² +46.2% YoY
Gross Margin (TTM)
51.8%β–² +1.7% YoY
Operating Income (TTM)
$132Mβ–² +46.2% YoY
Free Cash Flow (TTM)
$274Mβ–² +46.2% YoY

About CONMED CORP

CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors. These innovative offerings provide unique clinical advantages to orthopedic surgeons for repairing soft tissue injuries and are complemented by supportive tools that facilitate minimally invasive sports medicine operations. These orthopedic solutions are marketed under prominent brand names, including Hall, CONMED Linvatec, Concept, and Shutt. Furthermore, CONMED supplies general surgical equipment, encompassing items for clinical insufflation, smoke evacuation, electrosurgical interventions, and endomechanical applications. Its endoscopic technology segment provides both diagnostic and therapeutic instruments utilized in gastroenterological procedures, alongside products specifically designed for addressing conditions of the biliary system. The company also offers cardiac monitoring solutions, featuring ECG and EEG electrodes, and pads for cardiac defibrillation. CONMED distributes its diverse range of products directly to a wide array of healthcare facilities, including hospitals and surgical centers, and also leverages specialized medical distributors. Established in 1970, CONMED Corporation maintains its corporate headquarters in Largo, Florida.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
62/100

Analyst Price Target

β“˜
Average Target
$702.62
β–² +14.1% Upside
High Target$783.75
Low Target$609.41
Based on 23 analysts

Latest News & Updates